Pegloticase

Posted on September 22, 2008 by Gout Pal

Reduction of plasma urate levels following treatment with multiple doses of pegloticase (polyethylene glycol-conjugated uricase) in patients with treatment-failure gout: Results of a phase II randomized study.
Sundy JS, Becker MA, Baraf HS, Barkhuizen A, Moreland LW, Huang W, Waltrip RW 2nd, Maroli AN, Horowitz Z; Pegloticase Phase 2 Study InvestigatorsPegloticase Phase [...]

Filed under: Gout, Research, To Change on GoutPal, treatment, uric | Tagged: , | Leave a Comment »

Pegloticase

Posted on October 23, 2007 by Gout Pal

Press release from the manufacturers of Puricase®, a proprietary uric acid lowering treatment that has just been assigned the generic name, pegloticase.
Find more information about Puricase on GoutPal.com.

Savient Pharmaceuticals Completes Puricase(R) Phase 3 Studies for Treatment-Failure Gout
EAST BRUNSWICK, N.J., Oct 16, 2007 (BUSINESS WIRE) — Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) announced today the completion of [...]

Filed under: Gout, Research, uric | Tagged: , | Leave a Comment »